SCHEMBL8529758

SCHEMBL8529758

O=C1Nc2ccc(O)cc2C1=Cc1ccnc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 6/20 0.52
KDR P35968 2/20 0.52
PDGFRB P09619 2/20 0.52
PDGFRA P16234 1/20 0.52
FLT1 P17948 1/20 0.52
MAPT P10636 2/20 0.47
APP P05067 1/20 0.47
SNCA P37840 1/20 0.47
RECQL P46063 1/20 0.47
CHEK1 O14757 1/20 0.46
PLK4 O00444 3/20 0.45
PLK1 P53350 3/20 0.45
MAP3K7 O43318 1/20 0.45
TAB1 Q15750 1/20 0.45
RET P07949 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7131127 0.86 NTRK1 (0.47) KDRPDGFRBPDGFRAMAPTAPP
SCHEMBL8508649 0.86 RPS6KA3 (0.54) PDPK1CHEK1RETMEN1KMT2A
SCHEMBL8530158 0.85 RET (0.45) PDPK1RECQLCHEK1PLK4PLK1
SCHEMBL8301615 0.85 TLK2 (0.58) PDPK1KDRPDGFRBMAPTMEN1
SCHEMBL5728227 0.85 CHEK1 (0.60) KDRPDGFRBPDGFRAMAPTCHEK1
SCHEMBL5728224 0.85 CHEK1 (0.60) KDRPDGFRBPDGFRAMAPTCHEK1
SCHEMBL15503691 0.85 CHEK1 (0.60) KDRPDGFRBPDGFRAMAPTCHEK1
SCHEMBL8527796 0.84 SYK (0.51) PDPK1RECQLCHEK1MAP3K7TAB1
SCHEMBL1389087 0.84 PDPK1 (0.50) PDPK1KDRPDGFRBPDGFRAFLT1
SCHEMBL8530156 0.83 PDPK1 (0.55) PDPK1KDRPDGFRBPDGFRACHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed